Product Images Lanreotide Acetate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 33 images provide visual information about the product associated with Lanreotide Acetate NDC 69097-870 by Cipla Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - lanreotide acetate 01

The text appears to be a chemical formula with specific amino acid sequences and a variable X represented with a range of 1.0 to 2.0 that is multiplied by CH:COOH. It is likely a formula for a peptide.*

Figure 1 - lanreotide acetate 02

This is a graph showing the Progression-free Survival Probability (%) of subjects taking Somatuline Depot compared to Placebo. The graph also includes the Hazard Ratio (HR = 0.47) and the 95% confidence interval (0.30 - 0.73) with a p-value of less than 0.001. The number of subjects still at risk is displayed on the right-hand side and time in months is displayed on the bottom.*

fig 1 - lanreotide acetate 03

This appears to be a description of a needle pack containing a syringe. The pack includes a green needle shield, barrel, collar, and cap along with a plunger. The needle is presumably included within the pack as well. The accompanying figure may provide additional details on the organization and layout of the pack.*

fig 2 - lanreotide acetate 04

This is a product for the medical field that includes a clear needle cap with a green retractable shield for protection. The needle is visible through a round window for ease of use. Additionally, a needle pack is included with the needle already inside.*

fig 3 - lanreotide acetate 05

fig 4 - lanreotide acetate 06

fig 5 - lanreotide acetate 07

fig 6 - lanreotide acetate 08

fig 7 - lanreotide acetate 09

fig 8 - lanreotide acetate 10

fig 9 - lanreotide acetate 11

fig 10 - lanreotide acetate 12

fig 11 - lanreotide acetate 13

fig 12 - lanreotide acetate 14

fig 13 - lanreotide acetate 15

fig 14 - lanreotide acetate 16

fig 15 - lanreotide acetate 17

fig 16 - lanreotide acetate 18

fig 17 - lanreotide acetate 19

fig 18 - lanreotide acetate 20

The text is a cautionary message regarding a green needle shield, instructing not to touch it, and clarifying that it is not a cap. It is accompanied by a reference to "Figure 13", which is not available for interpretation without further context or information.*

fig 19 - lanreotide acetate 21

fig 20 - lanreotide acetate 22

fig 21 - lanreotide acetate 23

This text is a notice or warning about the importance of maintaining a 90-degree angle during a subcutaneous injection to achieve the correct depth. There is a reference to Figure 16, which may provide visual guidance or further information.*

fig 22 - lanreotide acetate 24

fig 23 - lanreotide acetate 25

Attention: Full retraction of the green needle shield is critical to ensure proper injection depth. Figure 18.*

fig 24 - lanreotide acetate 26

fig 25 - lanreotide acetate 27

fig 26 - lanreotide acetate 28

fig 27 - lanreotide acetate 29

fig 28 - lanreotide acetate 30

60 mg/0.2 mL Carton Label - lanreotide acetate 31

This is a product description for Lanreotide Injection, a medication provided in 60 mg syringes for deep subcutaneous injection. Each syringe also contains Lanreotide acetate and cumon water for injection. The recommended dosage is provided separately, and it should be stored in a refrigerator at 2°C t0 8°C to protect the medication from light. The product is manufactured by Pharmathen International, S.A. in Rodopl, Greece, and is distributed by Cipla USA, Inc. The box includes one pre-filled syringe and a safety needle. If there are any questions about the medication, please call 1-866-604-3268.*

90 mg/0.3 mL Carton Label - lanreotide acetate 32

Lanreotide Injection is a prescription medication administered through deep subcutaneous injection. Each syringe contains 90 mg of Lanreotide acetate in 0.3 ml of water for injection. It is recommended to store the medication in a refrigerator between 2°C to 6°C and protect it from light. The medication is manufactured by Resmathen Itomatona S.A. in Greece and marketed by Cipla USA, Inc. The box contains one prefilled syringe and one safety needle. If there are any questions related to Lanreotide injection, please contact the manufacturer.*

120 mg/0.5 mL Carton Label - lanreotide acetate 33

Lanreotide Injection is a prescription medication that contains Lanveolide 120 mg as Lanreotide acetate. A syringe of the medication includes 0.5 mL of a solution containing 120 mg of lanreotide base provided as lanreotide acetate in water. The medication is intended for deep subcutaneous administration by a healthcare professional, and the single-dose only product must be discarded if unused. A prefilled syringe and a safety needle are included in the pack. Lanreotide injection should be kept in its original box, in a refrigerator at 2°C to 8°C (36°F to 46°F) and protected from light. The manufacturer is Pharmathan International, S.A. and has been manufactured for Cipa USA, Inc. Contact 1.866-604.3263 for any questions.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.